Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

HPQ Silicon Inc V.HPQ

Alternate Symbol(s):  HPQFF

HPQ Silicon Inc. (HPQ) is a Canada-based technology company specializing in green engineering of silica and silicon-based materials. The Company is engaged in developing, with the support of technology partners PyroGenesis Canada Inc. (PyroGenesis) and Novacium SAS, new green processes to make the critical materials needed to reach net zero emissions. Its activities are centered around the three pillars: becoming a green low-cost (Capex and Opex) manufacturer of Fumed Silica using the Fumed Silica Reactor, a proprietary technology owned by HPQ being developed for HPQ by PyroGenesis; becoming a producer of silicon-based anode materials for battery applications with the assistance of Novacium SAS, and Novacium SAS is engaged in developing a low carbon, chemical base on demand and high-pressure autonomous hydrogen production system. The Company operates in a single operating segment, segment, being the sector of the transformation of quartz into silicon materials and derivative products.


TSXV:HPQ - Post by User

Post by Jamesdeon Dec 01, 2020 12:08pm
565 Views
Post# 32009890

COVID-19 Trial

COVID-19 Trial

Get moving and see significant factors on why you should go for healht sector.this could help us big time

 Food and Drug Administration  has authorized the initiation of study for the use of  (ultramicronized palmitoylethanolamide, or ultramicronized PEA) to treat COVID-19, the disease caused by the SARS-CoV-2 virus . These companies is expected to start dosing patients. We believe FSD201 may have the potential to address the over-exuberant inflammatory response characterized by COVID-19 infection that may lead to a cytokine storm and ultimately death.
 
Positive anything is better.Check disclaimer on profile
<< Previous
Bullboard Posts
Next >>